El DIAGNÓSTICO PRECOZ favorece el PRONÓSTICO de la Miastenia Gravis
1. Según las Formas Clínicas
2. Según los Tipos de Anticuerpos
BIBLIOGRAFÍA
- Andersen, J. B., Erik Gilhus, N. and Sanders, D. B. (2016), Factors Affecting Outcome in Myasthenia Gravis. Muscle Nerve. Accepted Author Manuscript. doi:10.1002/mus.25205. https://dx.doi.org/10.1002/mus.25205
- Bak, V., Spalek, P., Rajcok, M., Danihel, L. and Schnorrer, M. Importance of thymectomy and prognostic factors in the complex treatment of myasthenia gravis. (2016). Bratisl Lek Listy. 117(4), 195-200. https://www.ncbi.nlm.nih.gov/pubmed/27075381
- Wang, L.L., Zhang, Y. and He, M.L. (2015). Clinical Features and Prognosis of Ocular Myasthenia Gravis Patients with Different Phenotypes. Chin Med J ,128(19), 2682-2684. https://dx.doi.org/10.4103%2F0366-6999.166032
- Nikolic, A., Djukic, P., Basta, I., Hajdukovic, Lj., Stojanovic, V.R…and Lavrnic, D. (2013). The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients withgeneralized myasthenia gravis. Clin Neurol Neurosurg. 115(4), 432-437. https://dx.doi.org/10.1016/j.clineuro.2012.06.013
- Angelini, C. (2011). Diagnosis and management of autoimmune myasthenia gravis. Clin Drug Investig. 31(1):1-14. doi: 10.2165/11584740-000000000-00000
- Chen, X.J., Qiao, J., Xiao, B.G. and Lu, C.Z. (2004). The significance of titin antibodies in myasthenia gravis – correlation with thymoma and severity of myasthenia gravis. J Neurol. 251(8), 1006-1011. https://dx.doi.org/10.1007/s00415-004-0479-z
Miastenia y Salud: tu Web enfermera 